CSCI Research Brief

Cannabidiol (CBD) Lowers Diabetes Incidence in Mice

Weiss L, Zeira M, Reich S, et al. Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity. 2006;39(2):143-151. doi:10.1080/08916930500356674

This study is about the immune system responses and anti-inflammatory properties of CBD, which was shown to lower the incidence of diabetes in non-obese diabetic mice.  

Cannabidiol (CBC), a component of the cannabis plant, has shown anti-inflammatory properties and aspects of cell-mediated immunity. In response to an antigen, mature T cells, macrophages, and cytokines are released, which help drive cell-mediated immunity. Cell-mediated immunity results in inflammation and autoimmunity in disorders such as rheumatoid arthritis. CBD suppresses inflammation and some aspects of cell-mediated immunity.

CBD Lowers Diabetes Incidence in Mice: Study Findings

CBC suppressed cell-mediated autoimmune joint destruction in animal models with rheumatoid arthritis. This study discovered that CBD significantly reduced the incidence of diabetes in mice from 86% in non-treated control mice, to 30% in CBD-treated mice; the study also found CBD significantly reduced blood levels of proinflammatory cytokines. 

TH1-associated cytokine production of in vitro activated T-cells and peritoneal macrophages was also significantly lowered in mice treated with CBD. But TH2-associated cytokines increased in the CBD-treated mice, compared with the untreated mice. The pancreas islets of CBD-treated mice had a significant reduction in insulitis.

Conclusion

The study authors concluded “CBD can inhibit and delay destructive insulitis and inflammatory Th1-associated cytokine production in NOD [non-obese diabetic] mice resulting in a decreased incidence of diabetes possibly through an immunomodulatory mechanism shifting the immune response from Th1 to Th2 dominance.”Link to article: https://doi.org/10.1080/08916930500356674

General Disclaimer

Center for Scientific Cannabinoid Information (CSCI) has placed information, including links to other websites or content belonging to or originating from third parties, on this website as a service to the general public and for general informational and educational purposes only.  The information on this website is not intended to substitute particularized advice of specialists or qualified professionals.  No content on this website should ever be used as a substitute for direct advice from appropriate professionals or qualified specialists.  This website could include inaccuracies or typographical errors.  The materials on this website do not constitute medical advice, do not necessarily reflect the opinions of CSCI or any of its employees, agents, affiliates, or subsidiaries, and are not guaranteed to be correct, complete, or up‐to‐date.  The publications, articles, and information on this website are provided as is without warranty of any kind, either express or implied, regarding accuracy, adequacy, validity, reliability, availability, or completeness, and CSCI does not warrant, endorse, guarantee, or assume responsibility for the accuracy or reliability of any information included on this website from third-party websites linked through this website.  UNDER NO CIRCUMSTANCE SHALL CSCI HAVE ANY LIABILITY TO YOU FOR ANY LOSS OR DAMAGE OF ANY KIND INCURRED AS A RESULT OF THE USE OF THE INFORMATION CONTAINED ON THIS WEBSITE OR RELIANCE ON ANY SUCH INFORMATION PROVIDED ON THIS WEBSITE. YOUR USE OF THIS WEBSITE AND YOUR RELIANCE ON ANY INFORMATION ON THIS WEBSITE IS SOLELY AT YOUR OWN RISK.

You cannot copy content of this page